Tonix Pharma (TNXP) Misses Q2 EPS by 1405c
Tweet
Share
E-mailGet Alerts TNXP Hot Sheet
Join SI Premium – FREE
Tonix Pharma (NASDAQ: TNXP) reported Q2 EPS of ($19.28), $14.05 worse than the analyst estimate of ($5.23). Revenue for the quarter came in at $2.21 million versus the consensus estimate of $3.5 million.
For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gordon Haskett cuts TJX Companies rating to Accumulate
- Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
- Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
